Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-07-19
2011-07-19
Padmanabhan, Sreeni (Department: 1627)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S335000, C544S267000, C546S298000
Reexamination Certificate
active
07981901
ABSTRACT:
Methods and compositions for targeting cerebral circulation and treatment of headache include formulations comprising a pharmacologically active substance in a transdermal formulation, which is topically applied to an area of skin superficial to a carotid artery, a temporal artery, a vertebral artery, or to a tender spot associated with a headache. Particularly preferred formulations include a xanthine derivative (e.g., theophylline, caffeine, aminophylline), and may further comprise ketoprofen. Contemplated methods further include methods of advertising use of contemplated compositions.
REFERENCES:
patent: 5250529 (1993-10-01), Theoharides
patent: 5827832 (1998-10-01), Sandage et al.
patent: 5840755 (1998-11-01), Liedtke
patent: 5885597 (1999-03-01), Botknecht et al.
patent: 5897880 (1999-04-01), Drizen et al.
patent: 6582724 (2003-06-01), Hsu et al.
O'Banion, M. K., “COX-2 and Alzheimer's disease: potential roles in inflammation and neurodegeneration”, 1999, Exp. Opin. Invest. Drugs, 8(10), pp. 1523 and 1526.
Mohiuddin, A.A.; Bath, F.J.; Bath, P.M., “Theophylline, aminophylline, caffeine and analogues for acute ischaemic stroke”, 2000, Cochrane Database Systematic Reviews, 2, pp. 1 and 2.
Darco et al., “Fever from caffeine”, Mar. 1996, Allergy, vol. 51(3), abstract.
Barth PMW, “Theophylline, aminophylline, caffeine and analogues for acute ischaemic stroke”, Oct. 1996, Cochrane Database of Systematic Reviews, Issue 4, abstract.
Winslow; E.H. “Digitalis”, Jun. 1974, The American Journal of Nursing, vol. 74, No. 6, pp. 1062-1065.
Brater, DC; “Benefits and risks of toraseamide in congestive heart failure and essential hypertension”, Drug Safety, Feb. 1996, vol. 14, No. 2, abstract.
Carter Kendra D
Fish & Associates PC
Padmanabhan Sreeni
LandOfFree
Compositions and methods for targeting cerebral circulation... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions and methods for targeting cerebral circulation..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions and methods for targeting cerebral circulation... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2695916